Anti-dumping investigation concerning ATS-8 – International Trade Law Update #52
On August 2, 2021, DGTR issued notification initiating anti-dumping investigation concerning imports of (4R-Cis)-1,1-dimethylethyl-6-cyanomethyl-2,2-dimethyl-1,3-dioxane-4-acetate also known as ATS-8 from China.
ATS-8 is a key intermediate for manufacture of Atorvastatin Active Pharmaceutical Ingredient which is widely used to treat for lowering of excess cholesterol condition in the human beings.
Drug manufacturers importing and using ATS-8 are likely to adversely impacted.
The exporters, importers and the user industry have 37 days to file response before DGTR.